Cerevel Therapeutics
CERE
#1945
Rank
A$13.10 B
Marketcap
$71.91
Share price
0.00%
Change (1 day)
126.38%
Change (1 year)

Cerevel Therapeutics (CERE) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : A$0.90 Billion

According to Cerevel Therapeutics's latest financial reports the company's total liabilities are A$0.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerevel Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.83 B14.56%
2022-12-31A$0.72 B380.12%
2021-12-31A$0.15 B92.37%
2020-12-31A$79 M28.7%
2019-12-31A$61.39 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$47.87 B 5,217.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$64.85 B 7,103.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.47 B 2,174.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.62 B 2,079.47%๐Ÿ‡บ๐Ÿ‡ธ USA